US pharmacy pricing
Simulect Cost Without Insurance — US Pharmacy Price Guide
Lowest price found · US pharmacies
$4,733.79/fill
for Simulect, across the pharmacies in our data
US pharmacy prices — 20mg
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
| $4,733.79Lowest | $4,736.79 | $4,719.29 | |
| $4,733.79Lowest | $4,736.79 | $4,719.29 | |
| $4,923.88 | $4,926.88 | $4,719.29 | |
| $4,967.78 | $4,970.78 | $4,719.29 | |
| $4,998.06 | $5,001.06 | $4,719.29 | |
| $5,111.17 | $5,114.17 | $4,719.29 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Simulect.
Frequently asked questions
What's the cash price for Simulect (Simulect) in the US?
Our most recent US pharmacy data shows a low of roughly $4,733.79 for Simulect with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.
Does Simulect have a generic equivalent?
Generic and brand-name pricing for Simulect is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much will I pay for Simulect if I have insurance?
The cost of Simulect with insurance depends entirely on your specific plan's formulary and benefit design. Some plans may cover it with a standard copay, while others may require prior authorization or not cover it at all. Contact your insurance provider for details on your coverage and potential out-of-pocket costs. For patients using Medicare or Medicaid, coverage rules also apply. If your insurance does not cover Simulect or leaves you with high out-of-pocket expenses, using a prescription discount card at the pharmacy is a common strategy to seek a lower price.
Can I get a generic version of Simulect?
No. Simulect is the brand-name version of the drug basiliximab, manufactured by Novartis. A generic equivalent is not currently available on the market.